UBS upgrades Interroll to “neutral,” lowers price target on slower growth outlook
-- Interroll Group (SIX:INRN) has been upgraded to "neutral" from "sell" by UBS Global Research, with a new price...
-- Interroll Group (SIX:INRN) has been upgraded to "neutral" from "sell" by UBS Global Research, with a new price...
-- The dispute settlement body of the World Trade Organization (WTO) has agreed to China’s request to establish a...
-- Shares of Saia , Inc. (NASDAQ: NASDAQ:SAIA) fell sharply by 20% following the release of their first quarter...
-- Former U.S. President Joe Biden and his wife Jill Biden are set to attend the funeral of Pope Francis this...
-- Morgan Stanley has upgraded Volkswagen (ETR:VOWG_p) to Equal-weight from Underweight, while downgrading Renault ...
-- Brazil’s IPCA-15 consumer price index (BRIPCA=ECI) recorded a rise of 0.43 percent in the month leading up to...
The S&P Biotech sector (XBI) has outperformed the S&P 500 (^GSPC) since 2021. Yahoo Finance Senior Health Reporter Anjalee Khemlani sits down with Catalysts host Madison Mills to take a closer look at the healthcare sector (XLV), specifically Medpace Holdings (MEDP) and Intuitive Surgical (ISRG), as uncertainty grows on the impact of President Trump's policy changes. To watch more expert insights and analysis on the latest market action, check out more Catalysts here.
-- Mexico’s national economy experienced a 1.0 percent growth in February compared to January, according to data...
By Anton Bridge TOKYO (Reuters) -Japan’s biggest investment bank and brokerage Nomura Holdings (NYSE:NMR) recorded a 27% rise...
-- British currency risk management firm Argentex (LON:AGFX) announced on Friday a change in its executive...